News41 seconds ago
Societal value of lecanemab in Japan published in Neurology and Therapy
Stockholm, May 17, 2023 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced the publication of results from a simulation study evaluating...
